Humira vs Remicade
Adalimumab vs Infliximab · Comparison Guide
Quick Comparison
| Feature | Humira | Remicade |
|---|---|---|
| Generic Name | Adalimumab | Infliximab |
| Manufacturer | AbbVie | Janssen |
| Drug Class | TNF-alpha Inhibitor | TNF-alpha Inhibitor |
| Shared Conditions | RA, Crohn's, UC, Psoriasis, PsA, AS | |
Key Differences: Humira vs Remicade
Both are TNF inhibitors approved for similar conditions. Remicade is administered as an IV infusion at a clinic; Humira is a self-administered subcutaneous injection at home. Many patients prefer the convenience of home injection. Remicade requires infusion center visits (every 8 weeks) which may offer closer clinical monitoring. Multiple biosimilars are available for both.
💊 Humira (Adalimumab)
- Class: TNF-alpha Inhibitor
- Manufacturer: AbbVie
- Full Humira information →
💊 Remicade (Infliximab)
- Class: TNF-alpha Inhibitor
- Manufacturer: Janssen
- Full Remicade information →
Both are TNF inhibitors approved for similar conditions. Remicade is administered as an IV infusion at a clinic; Humira is a self-administered subcutaneous injection at home. Many patients prefer the convenience of home injection. Remicade requires infusion center visits (every 8 weeks) which may offer closer clinical monitoring. Multiple biosimilars are available for both.
Neither Humira nor Remicade is universally better — the right choice depends on your specific condition, disease severity, insurance formulary, and health history. Your prescriber will determine which is most appropriate based on your clinical situation. BiologicHealthPlus carries both and can help you compare your coverage and costs for either medication.
Switching between biologics is common. Your prescriber will evaluate your current treatment response and determine if a switch is appropriate. BiologicHealthPlus can coordinate the transition including prior authorization for your new medication.
Both Humira and Remicade are covered by most commercial insurance plans, Medicare Part D, and Medicaid with prior authorization. BiologicHealthPlus handles insurance verification and prior authorization for both medications at no charge. Most insured patients pay $0–$35/month through manufacturer copay programs.
Humira and Remicade both have high cash list prices ($4,000–$9,000/month range) but most commercially insured patients pay $0–$35/month through manufacturer savings programs. BiologicHealthPlus automatically enrolls every patient in all available savings programs at no charge.
✅ BiologicHealthPlus Carries Both Humira and Remicade
We handle insurance verification, prior authorization, copay enrollment, and free cold-chain delivery for both medications. Contact us and we'll help you understand your options and costs.
Medical Disclaimer: This comparison is for educational purposes only. The choice between Humira and Remicade should be made by your healthcare provider based on your specific medical history, disease severity, and individual circumstances. Last updated: July 2026.